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Alzheimer’s disease (AD) is regarded as a multifactorial disease characterized 
by a complex pathogenesis including a cholinergic deficit - due to degeneration of 
cholinergic projections from the basal forebrain - and the extracellular accumulation 
of amyloid beta (Aβ) peptide. Aβ containing 39 to 42 amino acids is the predomi-
nant component of the senile plaques that, together with neurofibrillary tangles, are 
regarded as the neuropathological hallmarks of AD (Sorrentino et al. 2014). Aβ may 
assume different conformations changing from random coil or α-helical monomers 
to β-sheet structures forming toxic oligomers and/or β-sheet mature fibrils. In this 
framework, we studied the effect of acetylcholine (ACh) on the conformation of Aβ 
by circular dichroism analysis. Moreover we investigated the ability of ACh to protect 
neuronal cells from the toxic action of amyloid peptide and to modulate the neuro-
inflammatory response occurring via the phospholipase A2 (PLA2). Results show 
that the amount of Aβ(25-35) β-strand raised linearly in absence of ACh, whereas it 
remained almost constant in presence of ACh. In addition, in a micelle solution mim-
icking the membrane environment ACh was found effective in increasing and stabi-
lizing the soluble and not toxic helical content of Aβ(25-35) suggesting that ACh is 
capable to preserve the soluble form of Aβ(25-35), reducing the incipit of Aβ aggre-
gation. In order to assess the neuro-protective ability of ACh against toxic Aβ(25-35) 
accumulation, we used neural cell (NCC) cultures containing both astrocytes and gli-
al cells prepared from brains embryos from timed pregnant Wistar rats and infused 
ACh for 48h. By immunostaining, we observed that ACh reduced Aβ(25-35)-induced 
cell death. Then, we tested the protective effect of ACh on inflammation induced by 
Aβ administration. NCC were challenged with Aβ(25-35) in the presence and absence 
of ACh and immunostained for astroglial and neuronal markers: results showed a 
reduction of the morphological features of astrogliosys in ACh treated cells. PLA2 
expression analysis corroborated these data also underlying that ACh can negatively 
regulate inflammation pathways in glial cells.
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